Deutsche Bank Ag\ Dare Bioscience, Inc. Transaction History

Deutsche Bank Ag\

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$0.79 - $1.7 $3,713 - $7,990	-4,700 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$0.72 - $0.9 $273 - $342	380 Added 8.8%	4,700 $3,000
Q3 2019 Nov 14, 2019	BUY	$0.74 - $0.87 $3,196 - $3,758	4,320 New	4,320 $3,000
Q4 2017 Feb 14, 2018	SELL	$2.16 - $3.35 $3,002 - $4,656	-1,390 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$2.63 - $3.52 $3,655 - $4,892	1,390	1,390 $4,000

7.23M

Ticker DARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,820,896
Market Cap $277M
Description
Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription pr...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.